Lv5
1100 积分 2025-02-25 加入
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
13天前
已完结
Foslevodopa/Foscarbidopa: A Review in Advanced Parkinson's Disease
13天前
已完结
Motor fluctuations in Parkinson disease - a mini-review of emerging drugs
2个月前
已完结
Discovery and structure − activity relationships of 2,4,5-trimethoxyphenyl pyrimidine derivatives as selective D5 receptor partial agonists
2个月前
已完结
D1 Agonist Improved Movement of Parkinsonian Nonhuman Primates with Limited Dyskinesia Side Effects
2个月前
已完结
Sublingual apomorphine in treatment of Parkinson’s disease: a review
4个月前
已完结
Inhaled levodopa for threatening impending OFF episodes in managing Parkinson’s disease
4个月前
已完结
The need for non-oral therapy in Parkinson's disease; a potential role for apomorphine
4个月前
已完结
皖公网安备34019202002308
